The place of fibrinolytic and antiplatelet-aggregation agents in therapy
Griguer, R.P.; Brochier, M.; Raynaud, R.
Annales de Cardiologie et d'Angeiologie 22(6): 461-472
1973
ISSN/ISBN: 0003-3928 PMID: 4772262 Document Number: 59071
Document emailed within 1 workday
Related Documents
Wang, Y.-m.; Cao, Y.-j.; Liu, C.-f.; Feng, P. 2007: The changes and effects of antiplatelet agents on platelet-leukocyte aggregation in patients with acute cerebral infarction Zhonghua Nei Ke Za Zhi 46(7): 562-565Guha, S.; Sardar, P.; Guha, P.; Deb, S.; Karmakar, R.; Chakraborti, P.; Mookerjee, S.; Deb, P.K.; De, R.; Dutta, A.; Chaudhuri, U. 2009: Dual antiplatelet therapy in ACS: time-dependent variability in platelet aggregation during the first week Indian Heart Journal 61(2): 173-177
Laufman, H. 1974: Empiric use of anticoagulant and fibrinolytic agents in surgical therapy American Surgeon 40(1): 15-21
Franzosi, M.G. 2001: Reperfusion after acute myocardial infarct with fibrinolytic therapy o combination reduced fibrinolytic therapy and a glycoprotein IIb/IIIa inhibitor: the GUSTO V study Italian Heart Journal. Suppl: Official Journal of the Italian Federation of Cardiology 2(9): 1034-1036
Bruseghini, L.; Vilageliu, J. 1978: ITA 104, a product of antiplatelet aggregation activity Archivos de Farmacologia y Toxicologia 4(1): 132-134
Momo, K.; Someya, K.; Tachiiri, T.; Mitsuoka, Y.; Nakamura, K.; Imai, S.; Ino, T.; Ohkubo, H. 1992: Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals Arzneimittel-Forschung 42(1): 32-39
Gomes, O.M. 1982: Antiplatelet agents: how much? which one? for whom? Arquivos Brasileiros de Cardiologia 38(1): 1-2
Ishikawa, K. 2003: Anticoagulant, antiplatelet agents Nihon Rinsho. Japanese Journal of Clinical Medicine 61(Suppl 4): 647-653
Coccheri, S. 2013: New antiplatelet agents: are we better off now than we were with aspirin? Clinical Advances in Hematology and Oncology: H&o 11(12): 787-790
De Caterina, R.; Blanco, A. 1992: Nitrates as antiplatelet agents Sangre 37(1): 31-38
De Gautard, G.; Perrier, A. 2014: Antiplatelet agents in secondary prevention of stroke Revue Medicale Suisse 10(446): 1902 1904-7
Bochenek, A.; Wilczyński, M.ła. 2006: Antiplatelet agents--problem for cardiac surgeon Kardiologia Polska 64(11): 1329-1331
Hegge, K.A. 2009: Antiplatelet agents for prevention of recurrent ischemic stroke South Dakota Medicine: the Journal of the South Dakota State Medical Association 62(1): 15-17
Zoja, C.; Perico, N.; Remuzzi, G. 1991: Antiplatelet agents: effects on the progressive renal disease American Journal of Kidney Diseases: the Official Journal of the National Kidney Foundation 17(5 Suppl 1: 98-102
Satoh, S. 2011: Usage of antiplatelet and anticoagulant agents in ischemic cardiomyopathy Nihon Rinsho. Japanese Journal of Clinical Medicine 69(Suppl 9): 423-427
Korbut, R.; Zmuda, A.; Basista, M.; Gryglewski, R.J. 1986: Eicosanoid balance at early stages of experimental atherosclerosis. its relationship with plasma fibrinolytic activity and platelet aggregation Agents and Actions. Supplements 20: 225-236
Teng, C.M.; Ko, F.N.; Wang, J.P.; Lin, C.N.; Wu, T.S.; Chen, C.C.; Huang, T.F. 1991: Antihaemostatic and antithrombotic effect of some antiplatelet agents isolated from Chinese herbs Journal of Pharmacy and Pharmacology 43(9): 667-669
Melandri, G.; Semprini, F.; Cervi, V.; Candiotti, N.; Branzi, A. 1994: Chronic ischemic cardiopathy: antiplatelet agents and anticoagulants, new protocols for prevention and treatment Cardiologia 39(12 Suppl. 1): 347-352
Kawana, S.; Katori, M.; Ohta, M.; Nishiyama, S. 1986: Microcirculatory changes during skin allograft rejection and prolongation of survival time by antiplatelet agents International Journal of Tissue Reactions 8(2): 119-128
Schaerlig, E. 2010: Echoes of the ESC 2010. Atrial fibrillation, rush on antiplatelet agents, genetics omnipresence Revue medicale suisse 6(270): 2151-2152